These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11602756)

  • 1. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.
    Maréchal V; Prevost MC; Petit C; Perret E; Heard JM; Schwartz O
    J Virol; 2001 Nov; 75(22):11166-77. PubMed ID: 11602756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1.
    Maréchal V; Clavel F; Heard JM; Schwartz O
    J Virol; 1998 Mar; 72(3):2208-12. PubMed ID: 9499078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
    Yonezawa A; Cavrois M; Greene WC
    J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.
    Liu NQ; Lossinsky AS; Popik W; Li X; Gujuluva C; Kriederman B; Roberts J; Pushkarsky T; Bukrinsky M; Witte M; Weinand M; Fiala M
    J Virol; 2002 Jul; 76(13):6689-700. PubMed ID: 12050382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor.
    Filice G; Cereda PM; Orsolini P; Soldini L; Razzini E; Campisi D; Gulminetti R
    Microbiologica; 1991 Apr; 14(2):77-93. PubMed ID: 1713289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious HIV-1 assembles in late endosomes in primary macrophages.
    Pelchen-Matthews A; Kramer B; Marsh M
    J Cell Biol; 2003 Aug; 162(3):443-55. PubMed ID: 12885763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Particle Tracking of Human Immunodeficiency Virus Type 1 Productive Entry into Human Primary Macrophages.
    Li Q; Li W; Yin W; Guo J; Zhang ZP; Zeng D; Zhang X; Wu Y; Zhang XE; Cui Z
    ACS Nano; 2017 Apr; 11(4):3890-3903. PubMed ID: 28371581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
    Zhou J; Aiken C
    J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 induces cellular polarization, intercellular adhesion molecule-1 redistribution, and multinucleated giant cell generation in human primary monocytes but not in monocyte-derived macrophages.
    Fais S; Borghi P; Gherardi G; Logozzi M; Belardelli F; Gessani S
    Lab Invest; 1996 Dec; 75(6):783-90. PubMed ID: 8973473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
    Harada T; Tatsumi M; Takahashi H; Sata T; Kurata T; Kojima A
    Microbes Infect; 2004 Apr; 6(5):421-8. PubMed ID: 15109956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo cytolysis and fusion of human immunodeficiency virus type 1-infected lymphocytes in lymphoid tissue.
    Orenstein JM
    J Infect Dis; 2000 Jul; 182(1):338-42. PubMed ID: 10882620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages.
    Stantchev TS; Broder CC
    J Infect Dis; 2000 Jul; 182(1):68-78. PubMed ID: 10882583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments.
    Gobeil LA; Lodge R; Tremblay MJ
    J Virol; 2013 Jan; 87(2):735-45. PubMed ID: 23115275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages.
    Walter BL; Wehrly K; Swanstrom R; Platt E; Kabat D; Chesebro B
    J Virol; 2005 Apr; 79(8):4828-37. PubMed ID: 15795268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human macrophages accumulate HIV-1 particles in MHC II compartments.
    Raposo G; Moore M; Innes D; Leijendekker R; Leigh-Brown A; Benaroch P; Geuze H
    Traffic; 2002 Oct; 3(10):718-29. PubMed ID: 12230470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macropinocytosis is the entry mechanism of amphotropic murine leukemia virus.
    Rasmussen I; Vilhardt F
    J Virol; 2015 Feb; 89(3):1851-66. PubMed ID: 25428868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.
    Ho SH; Martin F; Higginbottom A; Partridge LJ; Parthasarathy V; Moseley GW; Lopez P; Cheng-Mayer C; Monk PN
    J Virol; 2006 Jul; 80(13):6487-96. PubMed ID: 16775336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.
    Chertova E; Chertov O; Coren LV; Roser JD; Trubey CM; Bess JW; Sowder RC; Barsov E; Hood BL; Fisher RJ; Nagashima K; Conrads TP; Veenstra TD; Lifson JD; Ott DE
    J Virol; 2006 Sep; 80(18):9039-52. PubMed ID: 16940516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.